Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response



Status:Recruiting
Conditions:Gastrointestinal, Digestive Disease
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:11 - 18
Updated:9/20/2018
Start Date:April 23, 2018
End Date:September 2022
Contact:Rachel Unteutsch
Email:runteutsch@mcw.edu
Phone:4142664844

Use our guide to learn which trials are right for you!

Defining Adolescent Nausea Through Brain-Gut Physiology and Non-Invasive Neurostimulation Response

This study evaluates the efficacy of auricular neurostimulation via an non-invasive
percutaneous electrical nerve field stimulator (PENFS) in adolescents with functional nausea.
A neurostimulator is applied to the outer ear and stimulates several nerves that are thought
to be involved in transmission of nausea and vomiting signals. Half of the study subjects
will receive an active nerve stimulator while the other half will receive an inactive one.

By stimulating branches of several cranial nerves in the outer ear, this study aims to
improve symptoms and quality of life in adolescents with functional nausea.

The study has the following specific aims:

1. To define adolescent functional nausea into subtypes based on clinical characterization
and physiologic testing.

2. Evaluating the efficacy of auricular neurostimulation via PENFS for functional nausea.
Subjects will be randomized into two groups: 1) neurostimulation versus 2) sham. They
will receive either an active or non-active (sham group) device for 5 days each week x 4
weeks total. Those who do not improve will receive an additional 4 weeks of therapy with
active stimulation.

3. Investigate possible brain functional connectivity changes induced by auricular
neurostimulation compared to patients with irritable bowel syndrome and healthy controls

Inclusion Criteria:

- Meeting pediatric Rome IV criteria for functional nausea

- English-speaking and able to verbalize their condition and concerns about nausea, pain
and other symptoms

- Lack of other explanation for symptoms

- Intact external ear that is free of infection or severe dermatological conditions, - -
No currently implanted electrical device

Exclusion Criteria:

- Medically complex and/or suffering from medical condition that may explain symptoms

- Taking a medication that may explain symptoms

- Significant developmental delays

- Patients treated with a new drug affecting the central nervous system within 4 weeks
of study start

- Infection or severe dermatological condition of ear

- Currently implanted electrical device

- Patients with a history of severe allergy to adhesives
We found this trial at
1
site
9000 W Wisconsin Ave #270
Milwaukee, Wisconsin 53226
(414) 266-2000
Principal Investigator: Katja Kovacic, MD
Phone: 414-266-3695
Children's Hospital of Wisconsin Nothing matters more than our children. At Children's Hospital of Wisconsin,...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials